A case of a 58 year old woman with a chronic lymphoproliferative disorder of unusual clinical presentation, disease course, and immunophenotype is presented. At diagnosis she had severe anaemia, moderate lymphocytosis with some cells having prolymphocytoid features and a normal platelet count. A clinical examination yielded negative results. Only anaemia related symptoms were found and the patient became blood transfusion dependent. Both the lymphocytosis and the proportion of prolymphocytoid cells rose insidiously and thrombocytopenia developed later during the course of the disease. Three years later, the patient had a white cell count of 269 x 109I almost exclusively of prolymphocytoid cells and the bone marrow was diffusely infiltrated. She was refractory to chemotherapy and the anaemia did not improve after treatment with cyclosporine. Lymphoid cells were positive for cytoplasmatic CD3, HLA-Dr, CD34, CD38, CD7, CD56, CD13, CD33 and CD65. Membrane aft and y6 T cell receptors (TCRs) were not expressed and the /8 chain TCR gene was in germline configuration. Other membrane T, B, natural killer, and myelomonocytic markers were negative. Karyotype analysis was tried several times but metaphases were not obtained, even after stimulation with T cell mitogens. hospital in January 1990 because of anaemia and lymphocytosis. Both had first been noted six months earlier when she consulted her physician because of fatigue, dyspnoea, and palpitations. During that time she was not given any treatment.
Abstract A case of a 58 year old woman with a chronic lymphoproliferative disorder of unusual clinical presentation, disease course, and immunophenotype is presented. At diagnosis she had severe anaemia, moderate lymphocytosis with some cells having prolymphocytoid features and a normal platelet count. A clinical examination yielded negative results. Only anaemia related symptoms were found and the patient became blood transfusion dependent. Both the lymphocytosis and the proportion of prolymphocytoid cells rose insidiously and thrombocytopenia developed later during the course of the disease. Three years later, the patient had a white cell count of 269 x 109I almost exclusively of prolymphocytoid cells and the bone marrow was diffusely infiltrated. She was refractory to chemotherapy and the anaemia did not improve after treatment with cyclosporine. Lymphoid cells were positive for cytoplasmatic CD3, HLA-Dr, CD34, CD38, CD7, CD56, CD13, CD33 and CD65. Membrane aft and y6 T cell receptors (TCRs) were not expressed and the /8 chain TCR gene was in germline configuration. Other membrane T, B, natural killer, and myelomonocytic markers were negative. Karyotype analysis was tried several times but metaphases were not obtained, even after stimulation with T cell mitogens. hospital in January 1990 because of anaemia and lymphocytosis. Both had first been noted six months earlier when she consulted her physician because of fatigue, dyspnoea, and palpitations. During that time she was not given any treatment.
The blood picture at diagnosis was as follows: haemoglobin 55 g/l; platelet count 183 x 109/1; white cell count 14-6 x 109/1, with 88% lymphoid cells (20% of them displaying a prolymphocytoid morphology), and 12% neutrophils. No splenomegaly, hepatomegaly, lymphadenopathy, skin lesions, or other abnormal findings were noted on clinical examination. Serological evidence for hepatitis B virus, HIV, and Epstein-Barr virus infection was not found. A direct Coombs' test was negative.
A bone marrow aspirate showed the presence of a lymphoid infiltrate with 43% prolymphocytoid cells and 29% mature-looking lymphocytes. Sixteen per cent of the bone marrow cells were myeloid and 12% were erythroid elements with all maturation stages of these cell lineages being present. Lymphocyte immunophenotyping at that time was not helpful: bone marrow and peripheral blood lymphoid cells were positive for HLA-Dr and negative for CD 19, CD20, CDI 0, surface immunoglobulin (sIg), cytoplasmatic p chains (c,u) CD2, CD5, CD3, CD4, CD8, CD 14, CD1 3 and CD7 1. Cytochemical data were not available (table). A peripheral blood karyotype analysis was not possible because no metaphases were obtained after a 24 and 48h (7 Clin Pathol 1994; 47:461-463) Several attempts have been made to classify both acute and chronic leukaemias, most of them based on cell morphology.' 2 Nevertheless, immunophenotyping has helped considerably in the diagnosis of these hematological disorders,3 an immature phenotype usually being associated with an acute disease course. We describe a chronic lymphoproliferative disorder displaying an unusual immature immunophenotype. As far as we know no other case with these characteristics has been reported before. culture, both in the absence and in ence of phytohaemaglutinin (PHA immunoglobulin concentrations we: and monoclonal bands were not foa
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In spite of the prolymphocytoic of peripheral blood and bone cells, prolymphocytic leukaemia (I excluded by negativity for B and T c ated markers, absence of splenome only moderately increased white cell During the course of the dis patient became blood transfusion c and the white cell count rose insidio a variable but progressive rise in tht age of cells displaying prolymphocy phology.
By December 1990 the white c reached 95 x 109/1, the platelet c 154 x 109/1, and haemoglobin w; Clinical examination remained neg only symptoms related to anaer found. Treatment with chlorambucil dnisolone (four courses) was giver any obvious response.
In October 1991 the white cell c 100 x 109/1 and thrombocytope: noticed for the first time (platelets 5 The bone marrow and peripher immunophenotyping was repeated same panel of monoclonal antibodi used in December 1990, with simil to those obtained for the first study,4 a variable proportion of cells reac both CD 13 and CD33 myeloid E markers.
In January 1992 the lymphocyte phenotype was evaluated with an panel of monoclonal antibodies witl range of specificities. The ,the pres-lymphoid cells. Negativity for other T (CD2, L). Serum CD5, CD3, CD4, CD8) and B (CD 19, re normal CD20, CD22, CD10) cell lineage associated nd.
markers was confirmed. Genetic analysis I features showed that fi chain TCR was in germline marrow configuration. PLL) was Severe iron overload, due to multiple blood -ell associtransfusions, progressively developed and the -galy, and erythropoietin concentration was increased [counts.
(>200 mU/ml). Cyclosporin treatment was -ease, the therefore started in February 1992 for three lependent months. Not only did the patient fail to ously, with respond to this treatment but she also tolere percent-ated it very poorly. By February 1992 the ,toid mor-patient had become progressively and insidiously weaker, and experienced fatigue, -ell count anorexia, and weight loss. ount was By July 1992, the haematological picture as 50 g/l. was as follows: a white cell count of rative and 250 x 109/1; haemoglobin 50 g/l; and a platelet mia were count of less than 10 x 109/1. Both the peril and Prepheral blood smear and the bone marrow n without aspirate contained almost exclusively prolymphocytoid cells (figure) and a trephine biopsy :ount was specimen showed 70% haematopoietic cells, nia was almost exclusively represented by lymphoid 0 x 109/1). cells, described as "small lymphocytes with ral blood prominent irregular nucleoli". Acid using the phospatase was weakly positive with a nones as that polar distribution and myeloperoxidase and lar results Tdt were negative. Immunophenotyping except for studies showed reactivity with CD34, CD38, :ting with CD7, CD56 as well as with CD 13, CD33, associated and CD65. Other B (CD19, CD20, CD10), T (CD2, CD5, CD3, CD4, CD8), natural immunokiller (CD16, CD57, CD11b), and expanded myelomonocytic associated markers (CD14, h a broad CD1Ib, CD 15) were negative. Cytoplasmatic ure found CD3 (cCD3) was assayed for the first time, y for both and was strongly positive. Membrane acl3 and 5RA were yb TCR were not expressed and the 13 chain I on most TCR gene was in germline configuration.
Flow cytometric cell cycle analysis showed that peripheral blood lymphoid cells had a normal diploid DNA content with only 0 1% being at S phase (absolute S phase white cell count of 0-25 x 109/1). Karyotype analysis was tried again but no metaphases were obtained. HTLV1 was negative. In August 1992 combined chemotherapy with cyclophosphamide, vincristine, and prednisolone was started. After four courses the . . ; ; . . . white cell count fell from 269 to 23 x 109/1, ..but the haemoglobin concentration and platelet counts did not improve, and the patient remained profoundly anaemic and thrombocytopenic. She died in February 1993.
,°KM ,;,e iscussion In this report we have described a chronic lymphoproliferative disorder, with morphological evidence of a prolymphocytoid leukaemia and an unusual immunophenotype suggestive of immature T cell proliferation. In spite of the morphological prolymphocytoid features, several data argue against T-PLL. The unusual presentation with anaemia was the main clinical and laboratory feature; the Chronic prolymphocytoid leukaemia with an unusual immature immunophenotype insidious clinical course during which the white cell count progressively increased as did the percentage of prolymphocytoid cells but during which neither spleen nor liver enlarged; and finally, the unusual immunophenotype. In fact, a high white cell count, multiorgan disease, and an aggressive clinical course with a median survival of 7-5 months are characteristic features of T-PLL.4
Moreover, T-PLL has a more mature T cell phenotype expressing CD7, CD2, and CD5 on the cell surface, usually with membrane CD3 and being CD4(+), CD8(-).4 In this case only CD7 and cCD3 were expressed, suggesting an immature T cell phenotype. This was confirmed by the coexpression of CD34 and CD38. Expression of CD13 and CD33 myeloid associated markers is a relatively common feature in acute lymphoblastic leukaemia blast cells,5 being most typical in the most immature cases.6 The expression of cCD3 and the absence of reactivity for myeloperoxidase rule out the diagnosis of a myeloid disorder, and this agrees with the morphological findings. In spite of the immature phenotype, Tdt was negative and the disease took a chronic course, which militates against the possibility of a lymphoblastic leukaemia.7 The absence of growth after in vitro stimulation with a T cell mitogen (PHA) could also be related to the abnormal and immature phenotype. This is, in fact, another argument against a T-PLL in which metaphases are normally easily obtained after in vitro stimulation with PHA, and chromosomal abnormalities, often involving the chromosome band 14(1 1q) are observed.4 In spite of the immature phenotype the white cell count rose insidiously during the course of the disease, suggesting a low in vivo proliferative rate, which was confirmed by cell cycle analysis. The absence of enlarged organs could also be related to the immature phenotype and the absence of homing receptors, determining an accumulation in the bone marrow and peripheral blood without gross involvement of other haematopoietic organs.
Another hypothesis for diagnosis is a leukaemia of natural killer-cell lineage. These leukaemias include a heterogenous group of lymphoproliferative disorders with variable clinical manifestations, characterised by the proliferation of "large granular lymphocytes" which have natural killer cell activity, TCR genes in germline configuration, and a heterogenous immunophenotype, the main features being negativity for CD3 and variable expression of natural killer cell-assocated antigens.8 Indeed, this was our first presumed diagnosis, when immunophenotyping showed that the neoplastic clone was strongly positive for CD7 and CD56 and negative for surface CD3, and that the ,B chain TCR gene was in germline configuration. Several other factors, however, argue against this: large granular lymphocytes were never observed, lymphoid cells were positive for cCD3 and, finally, other natural killer cell associated markers were not expressed.
All these data would support the diagnosis of a T cell instead of a natural killer cell proliferation; to the best of our knowledge, no case with these characteristics has been reported before.
